Viewing Study NCT04112212


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2026-02-05 @ 9:10 PM
Study NCT ID: NCT04112212
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2019-09-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Using Vedolizumab-800CW to Gain Insight Into Local Drug Distribution and Mucosal Target Cells in IBD Patients
Sponsor: University Medical Center Groningen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-04
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2023-01-01
Completion Date Type: ACTUAL
First Submit Date: 2019-09-25
First Submit QC Date: None
Study First Post Date: 2019-10-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-14
Last Update Post Date: 2024-04-16
Last Update Post Date Type: ACTUAL